Literature DB >> 31172607

Randomized clinical study using xenograft blocks loaded with bone morphogenetic protein-2 or autogenous bone blocks for ridge augmentation - A three-dimensional analysis.

Daniel S Thoma1, Stefan P Bienz1, Michael Payer2, Jürg Hüsler1, Patrick R Schmidlin3, Christoph H F Hämmerle1, Norbert Jakse2, Ronald E Jung1.   

Abstract

OBJECTIVES: To test whether or not the use of a xenogeneic block loaded with rhBMP-2 results in superior radiological and profilometric outcomes compared to an autogenous bone block.
MATERIALS AND METHODS: Twenty-four patients randomly received a xenogeneic block loaded with rhBMP-2 (test) or an autogenous bone block (control) for primary augmentation. The ridge width (RW) was evaluated by means of a CBCT scan after augmentation surgery and at 4 months, prior to implant placement. Surface scans were taken prior to augmentation and at 4 months for profilometric analyses. Data were analyzed with Wilcoxon-signed rank test, Mann-Whitney test, or nonparametric ANOVA models.
RESULTS: The median RW after augmentation amounted to 7.13 mm (Q1 = 6.02; Q3 = 8.47) for test and 6.86 mm (Q1 = 5.99; Q3 = 8.95) for control. During 4 months of healing, the total RW decreased statistically significantly and measured 5.35 mm (Q1 = 4.53; Q3 = 6.7) for test and 5.15 mm (Q1 = 3.57; Q3 = 7.24) for control (p = 0.0005). The differences between the groups were not statistically significant (p > 0.5899). The buccal soft tissue contour slightly increased for test (0.83 mm; Q1 = 0.62; Q3 = 1.87) and control (1.16 mm; Q1 = 0.50; Q3 = 1.44).
CONCLUSIONS: Both treatment modalities successfully increased the ridge width to a similar extent. The shrinkage during healing was not greater in the test than in the control group. The impact of hard tissue augmentation on the soft tissue contour was, however, minimal.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CBCT; autogenous bone block; bone morphogenetic protein 2; bone regeneration; dental implants; guided bone regeneration

Mesh:

Substances:

Year:  2019        PMID: 31172607     DOI: 10.1111/clr.13492

Source DB:  PubMed          Journal:  Clin Oral Implants Res        ISSN: 0905-7161            Impact factor:   5.977


  6 in total

1.  Comparison of Bone Regeneration in Different Forms of Bovine Bone Scaffolds with Recombinant Human Bone Morphogenetic Protein-2.

Authors:  Hyun Seok; Hee-Youl Kim; Dong-Cheol Kang; Jung-Ho Park; Jong Hoon Park
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

Review 2.  Polymeric Scaffolds for Dental, Oral, and Craniofacial Regenerative Medicine.

Authors:  David T Wu; Jose G Munguia-Lopez; Ye Won Cho; Xiaolu Ma; Vivian Song; Zhiyue Zhu; Simon D Tran
Journal:  Molecules       Date:  2021-11-22       Impact factor: 4.411

3.  Clinical and radiographical performance of implants placed with simultaneous guided bone regeneration using resorbable and nonresorbable membranes after 22-24 years, a prospective, controlled clinical trial.

Authors:  Ronald E Jung; Lily V Brügger; Stefan P Bienz; Jürg Hüsler; Christoph H F Hämmerle; Nicola U Zitzmann
Journal:  Clin Oral Implants Res       Date:  2021-10-03       Impact factor: 5.021

Review 4.  Clinical applications of avian eggshell-derived hydroxyapatite.

Authors:  Horia Opris; Simion Bran; Cristian Dinu; Mihaela Baciut; Daiana Antoaneta Prodan; Alexandru Mester; Grigore Baciut
Journal:  Bosn J Basic Med Sci       Date:  2020-11-02       Impact factor: 3.363

5.  Preclinical Evaluation of BMP-9-Treated Human Bone-like Substitutes for Alveolar Ridge Preservation following Tooth Extraction.

Authors:  Fabien Kawecki; Jessica Jann; Michel Fortin; François A Auger; Nathalie Faucheux; Julie Fradette
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

6.  Informative title: Guided bone regeneration with and without rhBMP-2: 17-year results of a randomized controlled clinical trial.

Authors:  Ronald E Jung; Marionna N Kovacs; Daniel S Thoma; Christoph H F Hämmerle
Journal:  Clin Oral Implants Res       Date:  2022-01-08       Impact factor: 5.021

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.